ArticleFrontiers in public health2026
Community-driven secondary distribution of COVID-19 rapid antigen home tests in high-vulnerability Chicago neighborhoods: a community case study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
African American communities on Chicago's South and West Sides, many facing high levels of social vulnerability, experienced disproportionate COVID-19 burden driven in part by limited access to diagnostic testing early in the pandemic. In partnership with the Alive Faith Network (AFN), a longstanding coalition of African American churches and academic partners, we implemented a participant-driven model to expand access to rapid antigen home tests during October 2021-August 2022. Community members distributed 8,386 rapid antigen home tests through their social networks, reaching many individuals who were young, male, and unvaccinated. Survey data were received for 1,555 test kits (18%), representing 1,075 unique individuals, and 602 test results were received. Follow-up calls revealed high acceptability and willingness to test again. Despite a low response rate, this case study highlights how decentralized, trust-based distribution models can overcome structural and behavioral barriers to early detection and extend public health reach into populations historically under-served by conventional approaches, highlighting the value of trusted community infrastructures in advancing health equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.